YESID ALVARADO to Polypharmacy
This is a "connection" page, showing publications YESID ALVARADO has written about Polypharmacy.
Connection Strength
0.023
-
Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib. Cancer. 2011 Mar 01; 117(5):982-91.
Score: 0.023